INTEGRATED BIOPHARMA INC Operating Lease, Right-of-Use Asset, Amortization Expense
INTEGRATED BIOPHARMA INC (INBP) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $791.00 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-05-08
- INTEGRATED BIOPHARMA INC operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $288.00K, a 28.00% increase year-over-year.
- INTEGRATED BIOPHARMA INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $253.00K, a 7.66% increase year-over-year.
- INTEGRATED BIOPHARMA INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $250.00K, a 6.38% increase year-over-year.
- INTEGRATED BIOPHARMA INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-06-30 was $256.00K, a 5.79% increase year-over-year.
- INTEGRATED BIOPHARMA INC operating lease, right-of-use asset, amortization expense for fiscal 2025 was $951.00K, a 4.05% increase from fiscal 2024.
- INTEGRATED BIOPHARMA INC operating lease, right-of-use asset, amortization expense for fiscal 2024 was $914.00K, a 13.82% increase from fiscal 2023.
- INTEGRATED BIOPHARMA INC operating lease, right-of-use asset, amortization expense for fiscal 2023 was $803.00K, a 61.24% increase from fiscal 2022.
- INTEGRATED BIOPHARMA INC operating lease, right-of-use asset, amortization expense for fiscal 2022 was $498.00K, a 1.84% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month as first filed | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month as first filed | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $288.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $541.00K derived: sum of 2 quarters · filed 2026-05-08 | $791.00K 10-Q · filed 2026-05-08 | $1.05M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2025-12-31 | $253.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-11 | $503.00K 10-Q · filed 2026-02-11 | $759.00K derived: sum of 3 quarters · filed 2026-02-11 | $984.00K derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2025-09-30 | $250.00K 10-Q · filed 2025-11-10 | $506.00K derived: sum of 2 quarters · filed 2025-11-10 | $731.00K derived: sum of 3 quarters · filed 2026-05-08 | $966.00K derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2025-06-30 | $256.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $481.00K derived: sum of 2 quarters · filed 2026-05-08 | $716.00K derived: sum of 3 quarters · filed 2026-05-08 | $951.00K 10-K · filed 2025-09-23 | |||
| 2025-03-31 | $225.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $460.00K derived: sum of 2 quarters · filed 2026-05-08 | $695.00K 10-Q · filed 2026-05-08 | $937.00K derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | $235.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-11 | $470.00K 10-Q · filed 2026-02-11 | $467.00K 10-Q · filed 2025-02-13 | $712.00K derived: sum of 3 quarters · filed 2026-02-11 | $939.00K derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2024-09-30 | $235.00K 10-Q · filed 2025-11-10 | $232.00K 10-Q · filed 2024-11-13 | $477.00K derived: sum of 2 quarters · filed 2025-11-10 | $704.00K derived: sum of 3 quarters · filed 2025-11-10 | $928.00K derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $469.00K derived: sum of 2 quarters · filed 2025-09-23 | $693.00K derived: sum of 3 quarters · filed 2025-09-23 | $914.00K 10-K · filed 2025-09-23 | $902.00K 10-K · filed 2024-09-20 | ||
| 2024-03-31 | $227.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $451.00K derived: sum of 2 quarters · filed 2025-05-14 | $672.00K 10-Q · filed 2025-05-14 | $887.00K derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | $445.00K 10-Q · filed 2025-02-13 | $660.00K derived: sum of 3 quarters · filed 2025-02-13 | $874.00K derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-09-30 | $221.00K 10-Q · filed 2024-11-13 | $436.00K derived: sum of 2 quarters · filed 2024-11-13 | $650.00K derived: sum of 3 quarters · filed 2024-11-13 | $840.00K derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-20 | $429.00K derived: sum of 2 quarters · filed 2024-09-20 | $619.00K derived: sum of 3 quarters · filed 2024-09-20 | $803.00K 10-K · filed 2024-09-20 | |||
| 2023-03-31 | $214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-10 | $404.00K derived: sum of 2 quarters · filed 2024-05-10 | $588.00K 10-Q · filed 2024-05-10 | $712.00K derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $190.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-12 | $374.00K 10-Q · filed 2024-02-12 | $498.00K derived: sum of 3 quarters · filed 2024-02-12 | $621.00K derived: sum of 4 quarters · filed 2024-02-12 | |||
| 2022-09-30 | $184.00K 10-Q · filed 2023-11-09 | $308.00K derived: sum of 2 quarters · filed 2023-11-09 | $431.00K derived: sum of 3 quarters · filed 2023-11-09 | $556.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-15 | $247.00K derived: sum of 2 quarters · filed 2023-09-15 | $372.00K derived: sum of 3 quarters · filed 2023-09-15 | $498.00K 10-K · filed 2023-09-15 | |||
| 2022-03-31 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | $248.00K derived: sum of 2 quarters · filed 2023-05-11 | $374.00K 10-Q · filed 2023-05-11 | $499.00K derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-10 | $251.00K 10-Q · filed 2023-02-10 | $376.00K derived: sum of 3 quarters · filed 2023-02-10 | ||||
| 2021-09-30 | $126.00K 10-Q · filed 2022-11-10 | $251.00K derived: sum of 2 quarters · filed 2022-11-10 | |||||
| 2021-06-30 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $489.00K 10-K · filed 2022-09-13 | |||||
| 2021-03-31 | $364.00K 10-Q · filed 2022-05-12 |